Ssur Hf Stock Fundamentals
| OSSFF Stock | USD 5.33 0.00 0.00% |
Fundamental analysis of Ssur Hf allows traders to better anticipate movements in Ssur Hf's stock price by examining its financial health and performance throughout various phases of its business cycle.
Ssur |
ssur hf Company Return On Equity Analysis
Ssur Hf's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Ssur Hf Return On Equity | 0.0685 |
Most of Ssur Hf's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ssur hf is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, ssur hf has a Return On Equity of 0.0685. This is 100.29% lower than that of the Healthcare sector and 100.78% lower than that of the Medical Devices industry. The return on equity for all United States stocks is 122.1% lower than that of the firm.
ssur hf Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ssur Hf's current stock value. Our valuation model uses many indicators to compare Ssur Hf value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ssur Hf competition to find correlations between indicators driving Ssur Hf's intrinsic value. More Info.ssur hf is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers reporting about 0.48 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ssur hf is roughly 2.10 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Ssur Hf's earnings, one of the primary drivers of an investment's value.Ssur Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Ssur Hf's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Ssur Hf could also be used in its relative valuation, which is a method of valuing Ssur Hf by comparing valuation metrics of similar companies.Ssur Hf is currently under evaluation in return on equity category among its peers.
Ssur Fundamentals
| Return On Equity | 0.0685 | |||
| Return On Asset | 0.0326 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 2.3 B | |||
| Shares Outstanding | 420.29 M | |||
| Shares Owned By Institutions | 91.47 % | |||
| Price To Earning | 183.60 X | |||
| Price To Book | 3.20 X | |||
| Price To Sales | 2.72 X | |||
| Revenue | 718.65 M | |||
| Gross Profit | 439.75 M | |||
| EBITDA | 116.74 M | |||
| Net Income | 42.51 M | |||
| Cash And Equivalents | 66.8 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 277.71 M | |||
| Debt To Equity | 0.74 % | |||
| Current Ratio | 0.93 X | |||
| Book Value Per Share | 1.51 X | |||
| Cash Flow From Operations | 60.77 M | |||
| Earnings Per Share | 0.10 X | |||
| Number Of Employees | 3.89 K | |||
| Beta | 0.59 | |||
| Market Capitalization | 2.1 B | |||
| Total Asset | 1.33 B | |||
| Z Score | 4.2 | |||
| Net Asset | 1.33 B |
About Ssur Hf Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ssur hf's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ssur Hf using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ssur hf based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.ssur hf., together with its subsidiaries, designs, develops, produces, and sells non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. ssur hf. was founded in 1971 and is headquartered in Reykjavik, Iceland. Ossur HF is traded on OTC Exchange in the United States.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Other Information on Investing in Ssur Pink Sheet
Ssur Hf financial ratios help investors to determine whether Ssur Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ssur with respect to the benefits of owning Ssur Hf security.